These Were the Big S&P 500 Movers on Monday

Advancers

• Shares of solar equipment manufacturer Enphase Energy (ENPH) notched the top daily performance in the S&P 500, surging 9.8%. With the push higher on Monday, the stock recovered from a string of losses over the past week, in line with the slump in the broader market. Last week, Enphase launched shipments of the newest electric vehicle (EV) chargers in European markets.
  
• Intel (INTC) shares added 6.8%, extending gains posted late last week after the chipmaker named former board member 澳洲幸运5官方开奖结果体彩网:Lip-Bu Tan as its new♋ top executive. The semiconductor giant received an additional vote of confidence from a regulatory filing showing that the incoming CEO would purchase $25 million worth of Intel shares within 30 days of taking the reins of the company.
• Shares of electricity generator AES Corp. (AES) jumped 6.1%. Alongside other utilities, AES has drawn attention from investors for its opportunity to provide power for energy-intensive data centers, and according to reports, big tech firms account for more than 40% of the company's backlog. Last week, AES announced the pricing for its offering of $800 million in senior notes due in 2032. The company plans to use the proceeds from the offering to repurchase notes due in 2025.

Decliners

• Incyte (INCY) shares dropped 8.6%, losing the most of any S&P 500 stock after the pharmaceutical company released results from a Phase 3 clinical trial for an experimental skin care treatment. Although Incyte's povorcitinib reached its goal of reducing symptoms for the skin condition hidradenitis suppurativa (HS), the improvement for patients occurred at a lower rate than previous trials for the drug.
• Shares of Discover Financial (DFS) sank 6.9% following reports that U.S. Department of Justice (DOJ) officials have concerns about the credit card issuer's planned merger with Capital One Financial (COF). DOJ staff members reportedly believe the combination could limit competition in the subprime market. The potential regulatory resistance follows reports emerging last month that several states could file a lawsuit to block the deal. Capital One shares fell 3.8%.

• Tesla (TSLA) shares declined 4.8% after Mizuho analysts 澳洲幸运5官方开奖结果体彩网:cut their price target on theജ stock and reduced their forecast for the carmaker's vehicle deliveries. Mizuho's team pointed to weakening demand, headwinds in China, and issues with brand perception as factors behind the more muted outlook.

-澳洲幸运5官方开奖结果体彩网:Michael Bromberg

How Sustainable is the Current Rally?

The S&P 500 rose 0.6% on 🍌Monday after surging 2.1% on Friday, its best daily perfo𝓀rmance since the day after Donald Trump won re-election. For a second consecutive day, more than 90% of the S&P 500’s components closed higher.

The benchmark index 澳洲幸运5官方开奖结果体彩网:entered a correction for the first time since 2023 last week, a pullback 💯that Treasury Secretary Scott Bessent on Sunday called "healthy" and "norm🌌al."

Morgan Stanl𝓡ey analysts see a high probability of a short-term relief rally, but warned volatility will remain elevated this year and expresse🎀d skepticism about a sustained rebound into a bull market.

Read the 澳洲幸运5官方开奖结果体彩网:full article here.

-澳洲幸运5官方开奖结果体彩网:Colin Laidley

AMD Rises as Gaming GPUs Gain Market Share in Japan

Advanced Micro Devices (AMD) shares climbed Monday as the chipmaker’s gaming GPUs ga꧃ined market share in Japanꦡ.

At a product launch event in Japan, AMD said its latest Radeon series offerings have helped boost its market share to 45% in Japan, according to a report from Tom’s Hardware. The company competes with Nvidia (NVDA), which has been hindered by 澳洲幸运5官方开奖结果体彩网:supply chain issues.

Shares of AMD rose 3.6% Monday, but have lost nearly half of their value over the past 12 months amid concerns about the 澳洲幸运5官方开奖结果体彩网:chipmaker's AI revenue and ability to compete with Nvidia. Shares of Nvidia, meanwhile, have gained nearly 40% over that st🔴retch.

-澳洲幸运5官方开奖结果体彩网:Andrew Kessel

Some Analysts Feel It's Time to Bite on Chipotle Stock

Chipotle (CMG🐭) shares are having a rough 2025. Wall Street expects the burrito chain's stock to get back on track.

The company's shares fell less than 1% Monday, closing just below $50 to bring their year-to-date decline to about 18%, substantially underperforming the S&P 500. Lately, though, some analysts have shored up their support for the stock: Most recently, Oppenheimer reiterated an "outperform" rating, saying it’s time to take advantage of the fall.

The bank on Sunday said the stock's slide has Chipotle shares looking attractive even with some concern about near-term 澳洲幸运5官方开奖结果体彩网:same-store sales growth. “We believe [Chipotle] is one of the best positi✱oned for a powerful reboun🐽d in sales trends as industry headwinds subside,” Oppenheimer wrote.

Morgan Stanley, meanwhile, last week named Chipotle in its "Quality Stocks for a Long-Term Holding Period" report. The bank's analysts 澳洲幸运5官方开奖结果体彩网:turned bullish earlier thisꦐ month, raising their 𒐪price target to $70.

“We think that [Chipotle] is well positioned in fast casual, and among the best set up in the industry, to deploy next-generation technologies that drive cost savings and efficiency, which in turn protects the value proposition of the brand,” said Morgan Stanley's report.

Wall Street's consensus target is near $68, with most of the analysts following the stock having buy ratings, according to Visible Alpha. Oppenheimer’s target lands a couple dollars below that, at $66

-澳洲幸运5官方开奖结果体彩网:Jordyn Bradley

Novo Nordisk Stock Rises as Company Plans to Present Data

Novo Nordisk (NVO) shares rose Monday as the compa✤ny said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

The Danish drug developer is slated to take part in the American College of Cardiology Scientific Session𒅌 and Expo, which runs March 29 to 31. Its presentations “will provide new infor🐓mation about semaglutide medicines to reduce cardiovascular risk,” focusing on conditions including type 2 diabetes, obesity, peripheral arterial disease, and chronic kidney disease. 

Novo Nordisk shares rose nearly 4% on Monday, recovering some of the stock's losses last week following 澳洲幸运5官方开奖结果体彩网:disappointing results from a phase 3 trial of its in-development weight loss drug CagriSema.

Despite Monday's gains, shares of Novo Nordisk are down about 7% for the year so far, and have lost 40% of their value in the past 12 months.

-澳洲幸运5官方开奖结果体彩网:Andrew Kessel

What to Expect from Nvidia's GPU Technology Conference

Nvidia (NVDA) kicked off its weeklong GPU Technology Conference on Monday, with an eagerly awaited keynote address 🅘from CEO Jensen Huang scheduled for tomorrow.

Investors will be watching for updates on the company’s latest 澳洲幸运5官方开奖结果体彩网:artificial intelligence chips, upcoming🍸 releases, 🥃and developments in gaming and robotics.

The AI chipmaker is expected to showcase its 澳洲幸运5官方开奖结果体彩网:Blackwell Ultra GB300 🔯family of chips, which Deutsche Bank analysts said is expected to deliver over 50% mor⛄e memory capacity and significantly higher performance than its earlier Blackwell offerings.

 The timing of GB300’s rollout will be a focus, the analysts said, particularly as Nvidia has faced delays in 🎀fully ramping uꦛp Blackwell production.

Nvidia could also offer more details on its Rubin GPU, the suc𒆙cessor to Blackwell expected in 2026, along with its associated Vera CPU, and the Rubin Vera platform. It’s possible Huang’s keynote could offer breadcrumbs at what lies a generation beyond Rubin, analysts said.

GTC comes as Nv🤪idia’s stock has fallen 11% so far in 2025, creating a “compelling valuation” heading into the conference, anal🦋ysts at Bank of America said recently.

The analysts reiterated a “buy” rating and $200 price target, above the $177 average of analysts tracked by Visi🙈ble Alpha.

Nvidia shares fell 1.8% to $ꦏ119.53 on Monday, leading decliners among members of the Dow Jones Industrial Average.

Intel Continues Surging Amid Optimism About New CEO

Intel (INTC) stock was the biggest gainer on the Nasdaq in late💮 trading Monday following a report on incoming CEO Lip-Bu Tan's plans to turn around t💟he struggling chipmaker.

Citing two people familiar with Tan's thinking, Reuters reported that he is considering "significant changes" to Intel's manufacturing processes and its 澳洲幸运5官方开奖结果体彩网:artificial intelligence (AI) strategies.

Tan, who is 澳洲幸运5官方开奖结果体彩网:set to takeᩚᩚᩚᩚᩚᩚ⁤⁤⁤⁤ᩚ⁤⁤⁤⁤ᩚ⁤⁤⁤⁤ᩚ𒀱ᩚᩚᩚ over the t🐼op job Tuesday, is replacing Pat Gelsinger, who 澳洲幸运5官方开奖结果体彩网:retired late last year. Analysts and 澳洲幸运5官方开奖结果体彩网:investors have cheered the appointment, which Intel annou🧸nced last Wednesday.

Reuters reported Monday that Tan is weighing cuts to Intel's middle management ranks, and plans to prioritize bringing in new clients for its foundry business. Gelsinger had 澳洲幸运5官方开奖结果体彩网:moved to expand its contract manufacturing business to compete with global players like Taiwan Semiconductor Manufacturing Co. (TSM).

The report said analysts and Intel executives told the outlet that bringing on "at least two large customers to produce a high volume of chips" could make the foundry business successful. Intel did not immediately respond to an Investopedia request for comment.

On F𓆏riday, the company said in a regulatory filing that Tan would receive an initial base salary of $1 million, and added he has agreed to buy some $25 million in Intel stock in his first month on the job.

Intel shares were up 7% in recent trading, after gaining nearly 17% last week to lead S&P 500 gainers over the period. Despite Monday's gains, Intel shares are down about 40% from the same time a year ago.

-澳洲幸运5官方开奖结果体彩网:Aaron McDade

Mizuho Slices Tesla Price Target Amid Weakening Demand

Mizuho analysts trimmed their price target for Tesla (TSLA) stock, pointing to weakening demand for the company's vehicles and headwinds from China, amid 澳洲幸运5官方开奖结果体彩网:tariff uncertainty.

Mizuho said it now expects Tesla to deliver 1.8 milli💝on vehicles this year and 2.3 million in 2026, down from previous estimates of 2.3 million and 2.9 million, respectively. The drop comes as analysts estimate Tesla 𒁃“significantly underperformed the market” in the U.S. and China last month, as well as in Europe. 

Tesla’s struggles can be traced in part to a “deterioration in geopolitics" and brand perception, Mizuho analysts said. Tesla CEO Elon Musk has become 澳洲幸运5官方开奖结果体彩网:heavily involved in U.S. politics, running the Trump administration’s 澳洲幸运5官方开奖结果体彩网:Department of♍ Government Efficiency, with recent protests and reports of vandalism against Tesla vehicles raising concerns Musk's political activities could be𝓰 hu🉐rting sales. The analysts also pointed to growing competition in China from Chinese EV makers, and softer-than-expected demand for Tesla's Model Y refresh.

Mizuho cut its price target from $515 to $430. That's still well above the consensus target of about $367 from analysts tracked by Visible Alpha. 

Last week, analysts from Wells Fargo and JPMorgan 澳洲幸运5官方开奖结果体彩网:lowered their price targets to $130 and $120, respectively, suggesting the stock💛 could also have significant room to fall.

Tesla shares were down nearly 5% at around $238 in recent trading. The stock hasꦦ lost about half its value since hitting a record closing of 🃏$479.96 on Dec. 17.

-澳洲幸运5官方开奖结果体彩网:Andrew Kessel

Palantir Levels to Watch After 3-Week Losing Streak Snapped

Palantir Technologies (PLTR) shares were up slightly on Monday after gaining ground🌠 last week for the first time in four weeks.

Shares in the data analytics software company had come under pressure amid the political and economic uncertainty that has roiled financial markets, as well as specific concerns that reduced spending by the Department of Defense could cut into Palantir's business. The stock fell nearly 40% from its record high, set in mid-February, in less than three weeks.

The 澳洲幸运5官方开奖结果体彩网:stock bounced back last week after the AI investor favorite announced six 澳洲幸运5官方开奖结果体彩网:new large clients and inked a strategic product 澳洲幸运5官方开奖结果体彩网:partnership with Nvidia (NVDA)-backed startup, Databricks.

The shares found buying interest after the price filled an early-February 澳洲幸运5官方开奖结果体彩网:breakaway gap. However, more recently, the price has traded mostly sideways, indicating indecision among market participants. While the 澳洲幸运5官方开奖结果体彩网:relative strength index (RSI) sit📖s below the 50 threshold, the indicator climbed to its highest level in three weeks on Friday, signaling improving momentum.

Investors should watch key support levels on Palantir's chart around $85 and $66, while also monitoring important resistance levels near $100 and $125.

Palantir shares were up 0.6% at around🌜 $86.75 in rec🅠ent trading.

Read the full 澳洲幸运5官方开奖结果体彩网:technical analysis piece here.

-澳洲幸运5官方开奖结果体彩网:Timothy Smith

Incyte Tumbles on Skin Condition Drug Trial Results

Shares of Incyte (INCY) sank Monday, making it the biggest decliner in the S&P 500 after the release of its l♐atest clinical trial results.

The company issued the Phase III results for povorcitinib, an oral treatment for the skin condition hidradenitis suppurativa (HS). Incyte said both doses of the drug "met their primary endpoint" in the study, reducing the number of abscesses and inflammatory nodules caused by the disease by at least 50% compared to a placebo.

However, the rate at which patients reported a decreಞase in symptoms was lower than in previous trials for the s🌞ame drug.

Incyte said Monday that the drug's safety profile was similar to previous trials, and called the data a positive result. The company said the data supports its previous plans to submit the drug for regulatory approval.

"Given the limitations of current HS treatments and its impact on patients’ daily lives, there is a critical need for new, well tolerated and effective therapies that provide a rapid reduction in the signs and symptoms of HS, in particular, pain," Incyte Chief Medical Officer Dr. Steven Stein said.

Incyte shares were down around 10% Monday. The move is the stock's worst day since a 澳洲幸运5官方开奖结果体彩网:disappointing sales guide last month sent shares 7% lower.

-澳洲幸运5官方开奖结果体彩网:Aaron McDade

D-Wave Quantum Continues Soaring After Breakthrough Claim

Shares of D-Wave Quantum (QBTS) soared again Monday following last week's 澳洲幸运5官方开奖结果体彩网:announcement that its qu♈antum computer bested a superco♊mputer in a special task. 

D-Wave said in a press release last Wednesday announcing the publication of "a scientific breakthrough" in the journal Science that its "annealing quantum computer outperformed one of the world’s most powerful classical supercomputers in solving complex magnetic materials simulation problems with relevance to materials discovery."

CEO Dr. Alan Baratz called it "an industry first," arguing that D-Wave's "annealing quantum computers are now capable of solving useful problems beyond the reach of the world's most powerful supercomputers."

Since the announcement, shares of D-Wave𒈔 Quantum have roughly doubled. The stock was up 8% at around $11 in recent trading

Shares of another company in the sector, Quantum Computing (QUBT), have also 💧gotten a boost from D-Wave's announcement and were up 15% on Monday.

-澳洲幸运5官方开奖结果体彩网:Bill McColl

Affirm Tumbles as it Loses BNPL Deal With Walmart

Affirm (AFRM) shares tumbled Monday morning after rival Klarna, which is 澳洲幸运5官方开奖结果体彩网:preparing to go public in the U.S., said it is now the exclusive provider of 澳洲幸运5官方开奖结果体彩网:Buy Now, Pay Later (BNPL) loans for Walmart (WMT).

Klarna said it would be partnering with OnePay to provide Walmart consumers with installment loans this year. OnePay is a consumer fintech backed by Walmart and Ribbit Capital and is available in the retail giant's online and physical checkouts, according to a news release.

"This is a game changer,” Klarna CEO Sebastian Siemiatkowski said. “Millions of people in the U.S. shop at Walmart every day — and now they can shop smarter with OnePay installment loans powered by Klarna."

Once approved for a loan, con🔯sumers can choose within the OnePay app on repayment terms rang🦩ing from three months to three years. 

According to CNBC, which reported the news earlier, the more U.S.-focused Affirm ha⛄s been the exclusive provider for BNPL loans for Walmart since 2019.

Affirm sha๊res were down 11% in late-morning trading Monday. The stock is still up mor🍎e than 30% over the past 12 months.

-澳洲幸运5官方开奖结果体彩网:Nisha Gopalan

Norwegian Cruise Line Stock Rises After JPMorgan Upgrade

Norwegian Cruise Line Holdings (NCLH) shares advanced Monday when JPMorgan upgraded the stock after the🔯 cruise operator's executives brushed off warnings about a drop in trav𒅌el demand.

In a note to clients, JPMorgan said that it raised its rating to "overweight" from "neutral" after hosting CFO Mark Kempa and Head of Investor Relations Sarah Inmon at the bank's 2025 Gaming, Lodging, Restaurant & Leisure Conference in Las Vegas. 

The analysts said that the "definitive message" from the pair was that there was "zero detectable change in demand behavior to date despite 'noise' in the macro backdrop." That included "no change in booking curves to indicate irregular patterns, no cracks in onboard spend (including in high discretionary purchase categories of the Spa & Casino), and no change in cancellation rates."

JPMorgan added that Kempa and Inmon noted that while worries about tariffs have dominated the headlines recently, management hasn't seen any change in consumer spending patterns. In addition, the carrier isn't concerned about new taxes on the industry that were hinted at last month by Commerce Secretar🥃y Howard Lutnick.

Norwegian Cruise Line shares were up more than 3% in recent trading but have still lꦅost about 2༺3% since the start of the year.

-澳洲幸运5官方开奖结果体彩网:Bill McColl

S&P 500, Nasdaq Composite Down in 6 of Last 7 Weeks

The S&P 500 and Nasdaq Composite entered the week on four-week losing streaks,𝄹 and each has lost ground in six of theꦗ past seven weeks.

The S&P 500 and Nasdaq fell 2.3% and 2.4%, respectively, last week. The S&ꦺ;P 500, which🤡 hit a record high less than four weeks ago, has lost 7.6% during its seven-week slump, while the Nasdaq has plunged 11% during that stretch.

The 🍸Dow shed 3.1% last week, its worst weekly performance since March 2023. The Dow has fallen in four of the last six weeks, and has slipped into negative territory for the 🉐year.

Coming into Monday's session, the Dow has lost 2.5% since the start of 2025, while the S&P 500 and Nasdaq have declined 4.1% and 8.1%, respectively, over that period.

Gold Levels to Watch After Precious Metal Tops $3,000

Gold (XAUUSD) were little changed Monday morning after surpassing the $3,000/oz leve🐽l for the first time ever 🅠late last week.

The precious metal 澳洲幸运5官方开奖结果体彩网:received a boost last week as investors flocked to the 澳洲幸运5官方开奖结果体彩网:safe-haven asset amid concerns that the Trump administration’s 澳洲幸运5官方开奖结果体彩网:unpredictable tariff policies could slow econo🤪mic growth and accelerate inflation𒆙.

Gold consolidated within a two-week pennant before breaking out above the pattern’s top trendline last Thursday, signaling a continuation of the commodity’s longer-term uptrend.

Moreover, the 澳洲幸运5官方开奖结果体彩网:relative strength index (RSI) confirms bullish price momentum with a reading above 50, though a push this week into overbought territory could increase the likelihood of near-term 澳洲幸运5官方开奖结果体彩网:profit-taking.

Bars pattern analysis forecasts an upside target of around $3,365. Investors should watch crucial support levels on gold's chart near $2,833, $2,790, and $2,721.

Read the full 澳洲幸运5官方开奖结果体彩网:technical analysis piece here.

-澳洲幸运5官方开奖结果体彩网:Timothy Smith

Major Stock Index Futures Move Lower

Futures tied to the Dow Jon🎉es Industrial Average were down 0.4%.

S&P 500 futures slipped 0.2%.

Nasdaq 100 futures were off 0.1%.